Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We hypothesize that the use of MOBIDERM® after total knee prosthesis allows a greater and faster resorption of periarticular edema:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MOBIDERM group | Experimental |
| |
| Control group | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MOBIDERM | Device | Use of a MOBIDERM mobilizing band after total knee prosthesis |
|
| Measure | Description | Time Frame |
|---|---|---|
| Knee volume | unit: mm3 | Day -1 |
| Knee volume | unit: mm3 | Day 0 |
| Knee volume | unit: mm3 | Day 1 |
| Knee volume | unit: mm3 | Day 5 |
| Knee volume | unit: mm3 | Day 15 |
| Knee volume | unit: mm3 | Month 1 |
| Measure | Description | Time Frame |
|---|---|---|
| visual analog pain scale visual analog pain scale | visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt | Day 1 |
| visual analog pain scale visual analog pain scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nîmes University Hospital | Nîmes | 30029 | France |
Not provided
| ID | Term |
|---|---|
| D004487 | Edema |
| ID | Term |
|---|---|
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt
| Day 3 |
| visual analog pain scale visual analog pain scale | visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt | Day 5 |
| visual analog pain scale visual analog pain scale | visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt | Day 15 |
| visual analog pain scale visual analog pain scale | visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt | Month 1 |
| Knee injury and Osteoarthritis Outcome (KOOS) score | The Knee injury and Osteoarthritis Outcome Score (KOOS) is an instrument for measuring patient-reported outcomes. It assesses short-term and long-term consequences of knee injuries and consequences of primary osteoarthritis.The KOOS has 42 elements grouped into five distinct subscales: KOOS Pain ; KOOS Symptoms; KOOS Function, daily life; KOOS Activities, sports and recreation; KOOS quality of life. The KOOS score is a percentage from 0 to 100, with 0 representing extreme problems and 100 representing no problem. | day -1 |
| Knee injury and Osteoarthritis Outcome (KOOS) score | The Knee injury and Osteoarthritis Outcome Score (KOOS) is an instrument for measuring patient-reported outcomes. It assesses short-term and long-term consequences of knee injuries and consequences of primary osteoarthritis.The KOOS has 42 elements grouped into five distinct subscales: KOOS Pain ; KOOS Symptoms; KOOS Function, daily life; KOOS Activities, sports and recreation; KOOS quality of life. The KOOS score is a percentage from 0 to 100, with 0 representing extreme problems and 100 representing no problem. | day 15 |
| Knee injury and Osteoarthritis Outcome (KOOS) score | The Knee injury and Osteoarthritis Outcome Score (KOOS) is an instrument for measuring patient-reported outcomes. It assesses short-term and long-term consequences of knee injuries and consequences of primary osteoarthritis.The KOOS has 42 elements grouped into five distinct subscales: KOOS Pain ; KOOS Symptoms; KOOS Function, daily life; KOOS Activities, sports and recreation; KOOS quality of life. The KOOS score is a percentage from 0 to 100, with 0 representing extreme problems and 100 representing no problem. | month 1 |
| Measurement of knee flexion / extension | degree | Day -1 |
| Measurement of knee flexion / extension | degree | Day 0 |
| Measurement of knee flexion / extension | degree | Day 5 |
| Measurement of knee flexion / extension | degree | Day 15 |
| Measurement of knee flexion / extension | degree | Month 1 |
| Presence of an ecchymosis in proximity to the scar | Yes/no | Day 5 |
| Presence of an ecchymosis in proximity to the scar | Yes/no | Day 15 |
| Presence of an ecchymosis in proximity to the scar | Yes/no | Month 1 |
| Coloration of ecchymosis in proximity to the scar | Qualitative: red, pink, blue, purple, green, brown or yellow | Day 5 |
| Coloration of ecchymosis in proximity to the scar | Qualitative: red, pink, blue, purple, green, brown or yellow | Day 15 |
| Coloration of ecchymosis in proximity to the scar | Qualitative: red, pink, blue, purple, green, brown or yellow | Month 1 |
| Surface area of ecchymosis in proximity to the scar | Traced on OpSite Flexigrid® film: cm2 | Day 5 |
| Surface area of ecchymosis in proximity to the scar | Traced on OpSite Flexigrid® film: cm2 | Day 15 |
| Surface area of ecchymosis in proximity to the scar | Traced on OpSite Flexigrid® film: cm2 | Month 1 |
| Resolution of the ecchymosis in proximity to the scar | Patient and Observer Scar Assessment Scale (observer + patient) | Day 5 |
| Resolution of the ecchymosis in proximity to the scar | Patient and Observer Scar Assessment Scale (observer + patient) | Day 15 |
| Resolution of the ecchymosis in proximity to the scar | Patient and Observer Scar Assessment Scale (observer + patient) | Month 1 |